|
|
 |
|
AMLN: Amylin Pharmaceuticals Inc - Stock News |
Enter Ticker:
|
|
| Nov 16, 2009 |
TheFortuneFinancial.com Free Market Research on FNFG, ILMN, JDSU,AMLN, ISIL and BRCD |
| Nov 05, 2009 |
Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference |
| Nov 05, 2009 |
BenchmarkJournal.com Receives Analysis on CYOU, ESLR, DRYS, ETFC,AMLN and COMS |
| Nov 04, 2009 |
Japan co Takeda Pharma licenses US co Amylin for obesity drug |
| Nov 03, 2009 |
JAPAN'S TAKEDA IN DEAL WITH U.S. FIRM ON GLOBAL RIGHTS TO OBESITY DRUGS |
| Nov 03, 2009 |
Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals |
| Nov 03, 2009 |
Critical Alerts for ConocoPhillips, US Bancorp, CVS Caremark, Amylin, and Newell Rubbermaid Released by Seven Summits Research |
| Nov 02, 2009 |
Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's BYETTA(R) (Exenatide) Injection Update |
| Nov 02, 2009 |
Amylin Pharmaceuticals (AMLN) NewsBite - One of Today's Top Gainers On Takeda Deal |
| Nov 02, 2009 |
Dr. Stockpick Announces Daily Stock Watch - AMLN, VRTX, HGSI |
| Nov 01, 2009 |
Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity |
| Oct 30, 2009 |
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes |
| Oct 27, 2009 |
MWW, VRTX, BRCD, TIBX, AMLN and BMRN Free Research report onBenchmarkJournal.com |
| Oct 22, 2009 |
BioWest 2009 Registration Opens, Rolling Out A Stellar Lineup of National Speakers |
| Oct 22, 2009 |
Amylin Pharmaceuticals to Present at the 4th Annual BIOCOM Investor Conference |
| |
| ZACKS COMMENTARY FOR AMLN |
| Nov 18, 2009 | Zacks Blog: Good News for Alkermes’ Pipeline | | Nov 03, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals | | Nov 02, 2009 | Zacks Blog: Amylin Strikes First on Obesity | | Oct 21, 2009 | Zacks Blog: Amylin Loss Narrows | | Oct 21, 2009 | Zacks Equity Research: Report for AMLN | | Oct 14, 2009 | Zacks Blog: Good News for Alkermes’ Pipeline | | Sep 30, 2009 | Zacks Blog: Mixed News for Merck Drug | | Sep 11, 2009 | Zacks Blog: Amylin Collaborates with Biocon | | Aug 04, 2009 | Zacks Blog: Obesity Update For Arena | | Jul 24, 2009 | Zacks Blog: Diabetes Drug Gets an Edge | | Jul 23, 2009 | Zacks Blog: LAR Updates Overshadow Q2 Results | | Jul 21, 2009 | Zacks Blog: Amylin Gets Positive Results |
|
|
Sponsored Links 
-0.33